Within brain health, the robust demand for AD-detect blood tests for assessing Alzheimer's disease risk drives solid growth ...

Jack Meehan; Analyst; Nephron Research Erin Wright; Analyst; Morgan Stanley ...

Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

Blue Trust Inc. lifted its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 28.0% during the 4th ...

Any redistribution, retransmission or rebroadcast of this call in any form without the written consent of Quest Diagnostics, is strictly prohibited. I’d now like to introduce Shawn Bevec ...

Following the earnings announcement, Quest Diagnostics (NYSE:DGX)' stock price rose by 0.48% in pre-market trading. The stock ...

Barclays analyst Luke Sergott maintained a Hold rating on Quest Diagnostics (DGX – Research Report) today and set a price target of $168.00.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...